Gabapentin and Blood Glucose: No Hyperglycemia Risk; Possible Benefit

Gabapentin does not raise blood glucose. Evidence suggests neutral or modestly beneficial effects:

Clinical Data

  • RCTs in diabetic neuropathy: no worsening of glycemic control.
  • Some studies report reduced fasting glucose and improved insulin sensitivity (mechanism unclear; may involve reduced sympathetic tone or weight stabilization).
  • No signal for drug-induced hyperglycemia in FDA labels or pharmacovigilance.

Contrast With Other Agents

Unlike corticosteroids, atypical antipsychotics, thiazides, or beta-blockers, gabapentin lacks diabetogenic properties.

Monitoring

Routine glucose monitoring not required for gabapentin alone. In diabetic patients, continue standard surveillance; gabapentin unlikely to confound.

Weight Consideration

Gabapentin may cause peripheral edema and weight gain in some — monitor weight, not glucose specifically.

Patients with diabetes can use gabapentin for neuropathic pain without glycemic concern.

Diabetes - Related Articles